
Boston--A preoperative rise in serum PSA of >2.0 ng/mL predicts an increased mortality risk in patients with localized prostate cancer undergoing radical prostatectomy and might identify men who require additional therapy, investigators have concluded after reviewing outcomes in more than 1,000 cases.